DSMFF (DSM-Firmenich AG) Total Stockholders Equity: $20,537 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DSMFF DSM-Firmenich AG DSMFF
59 GF Score
Price $108.00
GF Value $88.77
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is DSM-Firmenich AG Total Stockholders Equity?

DSM-Firmenich AG DSMFF +18.28% 59 Total Stockholders Equity is $20,537 Mil as of Jun. 2026. GuruFocus rates DSMFF with a GF Score™ of 59/100 and a GF Value™ of $88.77 (Modestly Overvalued). The stock has 8 warning signs investors should review.

DSM-Firmenich AG's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $20,537 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. DSM-Firmenich AG's Book Value per Share for the quarter that ended in Jun. 2026 was $83.09. The ratio of a company's debt over equity can be used to measure how leveraged this company is. DSM-Firmenich AG's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.38.


DSM-Firmenich AG  (OTCPK:DSMFF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

DSM-Firmenich AG's Book Value per Share for the quarter that ended in Jun. 2026 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

DSM-Firmenich AG's Debt-to-Equity for the quarter that ended in Jun. 2026 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DSM-Firmenich AG Total Stockholders Equity Related Terms


DSM-Firmenich AG Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for DSM-Firmenich AG's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DSM-Firmenich AG Total Stockholders Equity Chart

DSM-Firmenich AG Annual Data
Trend Dec21 Dec23 Dec24 Dec25
Total Stockholders Equity
0.00 24,981.46 23,571.73 21,363.00

DSM-Firmenich AG Semi-Annual Data
Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Stockholders Equity Get a 7-Day Free Trial 23,810.55 23,571.73 24,627.45 21,363.00 20,536.87
DSMFF
59GF Score
DSM-Firmenich AG DSMFF
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $20,537 Mil mean?
DSM-Firmenich AG (DSMFF) has a Total Stockholders Equity of $20,537 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for DSM-Firmenich AG and its competitors.
Is DSM-Firmenich AG's Total Stockholders Equity too high?
DSM-Firmenich AG's current Total Stockholders Equity is $20,537 Mil. Overall, DSM-Firmenich AG has a GF Score™ of 59/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DSM-Firmenich AG's Total Stockholders Equity compare to LIN and SHW?
DSM-Firmenich AG's Total Stockholders Equity of $20,537 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Chemicals company?
A good Total Stockholders Equity depends on the Chemicals industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for DSM-Firmenich AG and its competitors. DSM-Firmenich AG's current Total Stockholders Equity is $20,537 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DSM-Firmenich AG stock overvalued right now?
Based on GuruFocus' analysis, DSM-Firmenich AG (DSMFF) is currently considered Modestly Overvalued. The stock's GF Value™ is $88.77, compared to a current price of $108.00 — trading 21.7% above its estimated fair value. The current Total Stockholders Equity is $20,537 Mil. DSM-Firmenich AG's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For DSM-Firmenich AG (DSMFF), the current Total Stockholders Equity is $20,537 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DSM-Firmenich AG (DSMFF) Overvalued in 2026?

Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued. The current stock price of $108.00 is trading 21.7% above its estimated GF Value™ of $88.77. GuruFocus considers DSM-Firmenich AG to be Modestly Overvalued.

Key valuation signals for DSMFF:

  • Total Stockholders Equity: $20,537 Mil
  • GF Value™: $88.77 vs. price of $108.00 (21.7% above fair value)
  • GF Score™: 59/100 with 8 warning signs

No single metric tells the full story. See the DSMFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DSM-Firmenich AG Business Description

Address Wurmisweg 576, Kaiseraugst, CHE, 4303
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
59GF Score

Get the complete analysis for DSMFF

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$108.00
Price
$88.77
GF Value